LexDanaLexDanabeta
Inventor

Iwan Beuvink

Inventor
Basel, CH

Overview

2→
Patents
2010–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
A61KPreparations for medical, dental or toiletry purposes17%
C07KPeptides17%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms17%
G01NInvestigating or analysing materials by determining their chemical or physical properties17%
PatentTitleYear
10,889,643Immune-stimulating humanized monoclonal antibodies against human interleukin-2, and fusion proteins thereof20217,749,698'p53 wild-type as biomarker for the treatment with mTOR inhibitors in combination with a cytotoxic agent'2010

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2010–2021Patents assigned to NOVARTIS AG (2)· patent assignee history
2010Based in Biel-Benken, CH· patent location history
2021Patents assigned to UNIV ZUERICH (1)· patent assignee history
2021Based in Basel, CH· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
NOVARTIS AG22010–2021
UNIV ZUERICH12021
Locations
LocationPatentsSpan
Basel, CH12021
Biel-Benken, CH12010